news on tirzepatide outperforms semaglutide in weight loss for overweight and obese adults FDA says shortage of popular

Frequency changes across the cycle, not the dose size

China has now approved GLP-1 therapies from Eli Lilly (Mounjaro), Innovent Biologics (mazdutide), and Guangzhou Innogen (efsubaglutide alfa), in addition to Xianyida

45 (Suppl): S19S26

Following the SUSTAIN-6 findings, the Ozempic Summary of Product Characteristics (SmPC) and specialist ophthalmology guidance emphasise the importance of: Assessing retinopathy status before initiating semaglutide Ensuring patients are up-to-date with diabetic eye screening Considering the rate of anticipated glycaemic improvement More frequent monitoring in high-risk individuals The consensus among UK diabetes specialists is that semaglutide remains an important therapeutic option, but prescribers should exercise particular caution in patients with established retinopathy and poor baseline glycaemic control

The retatrutide comparison data and availability information provide more context on this emerging treatment

Kaur G, Gupta V, Singhal R, Rawal R, Bansal P (2020b) Isolation of catechins from Roscoea purpurea